Home>Topics>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. UPDATE 1- FDA warns common uterine fibroid surgery can spread undetected cancer

    Headlines

    Thu, 17 Apr 2014

    April 17 (Reuters) - The U.S. Food and Drug Administration warned that a common surgical procedure used to remove uterine fibroids could spread undetected uterine cancer.

  2. Arzerra gets label expansion

    Headlines

    Thu, 17 Apr 2014

    The FDA approves Glaxo ( GSK ) and Genmab's ( OTC:GNMSF ) monoclonal antibody Arzerra (ofatumumab) as a first-line therapy for

  3. Merck gets another allergy drug in its quiver

    Headlines

    Thu, 17 Apr 2014

    The FDA clears Merck's ( MRK +0.5% ) sublingual Ragwitek to treat short ragweed ..... s immunotherapy treatment for allergies to five types of grass pollen. The FDA approved the company's complementary product, Grastek, a few days ago

  4. Syneron Medical's CEO Discusses FDA Clearance of the UltraShape System - Conference Call Transcript

    Headlines

    Thu, 17 Apr 2014

    Syneron Medical Ltd., ( ELOS ) FDA Clearance of the UltraShape System Conference Call April 17, 2014, 8:30 AM ET Executives Zack Kubow – Investor Relations The Ruth Group

  5. FDA warns common uterine fibroid surgery can spread undetected cancer

    Headlines

    Thu, 17 Apr 2014

    April 17 (Reuters) - The U.S. Food and Drug Administration warned that a surgical procedure used to mince uterine fibroids and remove them through a tiny abdominal incision could spread cancer tissue beyond the uterus in women with undetected uterine cancer.

  6. FDA wants stronger warning labels for long-acting opioids

    Headlines

    Thu, 17 Apr 2014

    April 17 (Reuters) - The U.S. Food and Drug Administration is requiring labels of all long-acting opioids to say they should be used strictly for patients in severe pain, a response to surging overdoses and deaths each year from the widely used pain medicines.

  7. New issue TriVascular up 27% from IPO price

    Headlines

    Thu, 17 Apr 2014

    an endovascular stent graft for the repair of an abdominal aortic aneurysm. It received CE Mark approval in August 2010 and FDA approval in October 2012. Commercial sales began in the U.S. in November 2012. Revenues for 2012 and 2013 were $5.4M

  8. Mylan launches generic transdermal contraceptive

    Headlines

    Thu, 17 Apr 2014

    pregnancy in women who use a transdermal patch as a method of contraception. According to IMS Health, Mylan has 300 ANDAs pending FDA approval representing $104.5B in branded sales. 42 are first-to-file submissions representing over $25B in branded sales

  9. New Morningstar Analyst Report for Crown Holdings Inc

    Stock Reports

    Thu, 17 Apr 2014

    lead to more volatile results. Many of Crown's cans are lined with bisphenol A. Although the U.S. Food and Drug Administration currently allows BPA in food packaging, there have been growing concerns about the substance's impact

  10. e-cig adverse events on the rise

    Headlines

    Thu, 17 Apr 2014

    and cardiovascular problems. Over the past 12 months, 50 complaints were filed with the FDA which matches the total for the previous five years. The FDA is poised to regulate the $2B industry which some observers believe will overtake tobacco

« Prev12345Next »
Content Partners